Anixa Biosciences (ANIX) Divestments (2010 - 2013)

Anixa Biosciences' (ANIX) quarterly Divestments came in at $1135.0 in Q1 2013, down 98.82% on a QoQ basis from $95888.0 in Q2 2011.

Anixa Biosciences (ANIX) Divestments (2010 - 2013) Analysis & Trends

Anixa Biosciences (ANIX) has 3 years of Divestments data on file, last reported at $1135.0 in Q1 2013.

Quarterly Divestments changed N/A year-over-year to $1135.0 in Q1 2013, while the trailing twelve-month figure through Jul 2013 was $1135.0 (changed N/A YoY) and the FY2012 annual result came in at $1000.0, down 99.16% from the prior year.
Divestments fell to $1135.0 in Q1 2013, from $95888.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $95888.0 in Q2 2011 to a low of $1135.0 in Q1 2013.
A 3-year average of $31195.5 and a median of $13879.5 in 2010 frame the typical range for Divestments.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Vertex Pharmaceuticals	139.69 Bn	131.84 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.46 Bn	78.47 Bn	3.93 Bn	-
3	Argenx Se	65.62 Bn	60.44 Bn	1.37 Bn	-
4	Moderna	58.37 Bn	53.24 Bn	52.00 Mn	-
5	BeOne Medicines	42.17 Bn	37.07 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.73 Bn	28.43 Bn	992.69 Mn	-
7	BioNTech SE	28.27 Bn	9.87 Bn	668.28 Mn	-
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	-
9	Royalty Pharma	27.23 Bn	26.40 Bn	-	-13.21 Mn
10	Anixa Biosciences	125.81 Mn	125.81 Mn	-	-

Download Data